Trademark: 97433023
Word
TILRAY MEDICAL
Status
Pending
Status Code
651
Status Date
Thursday, November 16, 2023
Serial Number
97433023
Mark Type
3000
Filing Date
Friday, May 27, 2022

Trademark Owner History

Classifications
41 Providing entertainment information in the field of cannabis culture via a website; providing news via a website in the nature of current event reporting in the field of cannabis and cannabis culture; providing educational information in the field of cannabis-themed cultural events and festivals via a website
5 Cannabis related products, namely, medicated oils, salves, tinctures, tablets and capsules, each containing cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils, salves, tinctures, tablets and capsules each containing resins and oils derived from cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of cannabis, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, bar and liquid soaps, bath additives, bath herbs, bath oils, body creams, body oils, face and body lotions, face and body milk, face lotion, and skin care preparations each containing derivatives of cannabis, for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; personal sexual lubricants; transdermal patches containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays containing cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis for medicinal purposes, namely gummy vitamins for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis related product, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; none of the foregoing containing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis
44 Providing the breeding, growing, cultivation, and harvesting of cannabis for others; production of cannabis, namely, cultivation of cannabis plants, for others; none of the foregoing services featuring or providing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis
31 Live cannabis plants; Cannabis seeds for agricultural purposes; derived solely from hemp plants containing no more than .3 percent delta-9 tetrahydrocannabinol (THC) concentration by dry weight basis
42 Research services, namely, medical, scientific, foods, cosmetic, product, and agricultural research in the area of cannabis, cannabis related products, derivatives of cannabis, and natural health products containing cannabis; none of the foregoing services featuring or providing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis
The mark consists of a stylized sideways "V" with three sun rays radiating out from the center of the "V" and to the right of the "V" the stylized word TILRAY above the word MEDICAL.
Color is not claimed as a feature of the mark.
"MEDICAL"

Trademark Events
Jan 30, 2024
Teas Response To Suspension Inquiry Received
Nov 16, 2023
Notification Of Inquiry As To Suspension E-Mailed
Nov 16, 2023
Inquiry To Suspension E-Mailed
Nov 16, 2023
Suspension Inquiry Written
May 19, 2023
Notification Of Letter Of Suspension E-Mailed
May 19, 2023
Letter Of Suspension E-Mailed
May 19, 2023
Suspension Letter Written
Apr 26, 2023
Teas/Email Correspondence Entered
Apr 25, 2023
Correspondence Received In Law Office
Apr 25, 2023
Teas Response To Office Action Received
Oct 31, 2022
Notification Of Non-Final Action E-Mailed
Oct 31, 2022
Non-Final Action E-Mailed
Oct 31, 2022
Non-Final Action Written
Oct 24, 2022
Assigned To Examiner
Aug 1, 2022
Assigned To Examiner
Aug 1, 2022
Assigned To Examiner
Jun 4, 2022
Notice Of Design Search Code E-Mailed
Jun 3, 2022
New Application Office Supplied Data Entered
May 31, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24